Skip to main content

Table 3 Adverse events reported in the included RCTs

From: Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials

Adverse Events

Studies Reporting (n)

ACEI/ARB Group (n/n)

Control Group (n/n)

RR (95% CI)

P Value

Hyperkalemia

5

33/604

24/605

1.29 (0.76,2.17)

0.34

Hypotension

5

54/604

54/605

1.03 (0.73,1.45)

0.87

Cough

2

3/75

0/77

2.63 (0.00,39,507.62)

0.84